Clinical Practice: evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin - Université Pierre et Marie Curie Accéder directement au contenu
Article Dans Une Revue Frontiers in Neurology Année : 2017

Clinical Practice: evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

Résumé

Cervical dystonia (CD) is the most frequent form of focal dystonia. Symptoms often result in pain and functional disability. Local injections of botulinum neurotoxin are currently the treatment of choice for CD. Although this treatment has proven effective and is widely applied worldwide, many issues still remain open in the clinical practice. We performed a systematic review of the literature on botulinum toxin treatment for CD based on a question-oriented approach, with the aim to provide practical recommendations for the treating clinicians. Key questions from the clinical practice were explored. Results suggest that while the beneficial effect of botulinum toxin treatment on different aspects of CD is well established, robust evidence is still missing concerning some practical aspects, such as dose equivalence between different formulations, optimal treatment intervals, treatment approaches, and the use of supportive techniques including electromyography or ultrasounds. Established strategies to prevent or manage common side effects (including excessive muscle weakness, pain at injection site, dysphagia) and potential contraindications to this treatment (pregnancy and lactation, use of anticoagulants, neurological comorbidities) should also be further explored.
Fichier principal
Vignette du fichier
fneur-08-00035.pdf (183.87 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-01496300 , version 1 (27-03-2017)

Licence

Paternité

Identifiants

Citer

Maria Fiorella Contarino, Joost D van den Dool, Yacov D Balash, Kailash D Bhatia, Nir D Giladi, et al.. Clinical Practice: evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin. Frontiers in Neurology, 2017, 8, pp.35. ⟨10.3389/fneur.2017.00035⟩. ⟨hal-01496300⟩
492 Consultations
228 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More